InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,732.93
(
0.25%
)
US TECH 100
19,349.20
(
-0.34%
)
Dow Jones
42,208.22
(
0.20%
)
Brent Oil
74.40
(
-0.21%
)
Bitcoin
63,885.71
(
-0.60%
)
Post# of 1509
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

joseytheoutlawwales

Send PM Follow Ignore
Followers 131
Posts 7841
Boards Moderated 0
Alias Born 12/17/2009

joseytheoutlawwales

Re: gators1381 post# 72

Wednesday, 06/21/2017 8:37:48 AM

Wednesday, June 21, 2017 8:37:48 AM

Post# of 1509
It's a battlefield in the stim market right now, and MRI ability is one of the points of contention.

Nuvectra will be conditional for extremity only; and depends upon where the device is placed in the spine (typical for all companies).

Medtronic has full-body with their main device (as well as the new Intellis system that will hopefully be approved this year by FDA).

Boston has a full-body device, but it's larger; i.e. Possible patient discomfort. Their Spectra is conditional for head only.

So Nuvectra's move is a GOOD one, stays competitive.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up